KMC Speciality Hospitals' record is built on clean revenue quality and operating cash flow that has covered reported profit in every year since FY2022. The strain sits in the company's relationship with its promoter holding company: a ₹98.57 crore guarantee for SKMC's bank loan, a proposed ₹65 crore related-party limit including a cash-paying land swap, and a 3.5x expansion of borrowing capacity to ₹700 crore. The FY2025-26 audit also introduced CARO exceptions, delays in PF/ESI/income-tax remittances and disputed statutory dues.
Key findings
- KMC guarantees its holding company's borrowings and seeks approval for a cash-paying land swap
Major- KMC provided a corporate guarantee not exceeding ₹98.57 crore (60% of tangible net worth as on 31 March 2025) for a loan availed by holding company Sri Kauvery Medical Care (India) Limited from State Bank of India on 11 Feb 2026. Shareholder approval is sought for material related-party transactions with SKMC for FY 2026-27 with an aggregate limit of ₹65 crore, representing 21.26% of the listed entity's annual consolidated turnover for FY 25-26. The proposed land exchange involves SKMC transferring \~24,864 sq. ft. at Royal Road and KMC transferring \~14,500 sq. ft. at Alexandria Road, with KMC paying differential consideration not exceeding ₹13.60 crore to SKMC. - Borrowing capacity expands 3.5x while promoter holding company encumbers 46.93% of its shares
Major- The board seeks shareholder approval to increase the Section 180(1)(c) borrowing limit from ₹200 crore (approved at AGM on September 28, 2020) to ₹700 crore, citing "business requirements and strategic expansion plans". On August 5, 2026, promoter SKMCIL disclosed an indirect encumbrance over 2,39,43,147 of its equity shares, aggregating 46.93% of fully diluted shareholding, comprising a pledge over 74,10,831 shares (14.53%) and a non-disposal undertaking over 1,65,32,316 shares (32.40%), securing non-convertible debentures issued by Prospera Healthcorp Private Limited under a debenture trust deed dated July 6, 2026. SKMCIL holds 75% of KMC, making this an indirect encumbrance on the listed company. - Supreme Court property dispute resolved in 2024; minimum-wage dispute stayed since 2018
Minor- The Supreme Court partly allowed the appeal in V.S. Palanivel Vs. P. Shriram CS Liquidator and KMC Speciality Hospitals (India) Limited on 28 Aug 2024, upholding the auction and sale of property to KMC and directing payment of an additional ₹5 crore to the Liquidator with 9% p.a. interest from 26.03.2020. On 16 Sep 2024, KMC remitted ₹7,01,57,534 towards the additional amount plus applicable interest, complying with the order in entirety. The Tamil Nadu Minimum Wages Act revision (GO dated 2 Mar 2018) was challenged by AHPI, of which KMC is a member, with an interim stay granted on 31 May 2018. - Revenue quality is clean on paper, but earlier disclosures show receivables concentration and credit-period creep
Minor- No customer accounted for more than 10% of revenue for FY2026 or FY2025, and unbilled revenue stood at ₹6.06 crore as at March 31, 2026 versus ₹4.07 crore as at March 31, 2025, all aged less than 6 months. However, trade receivables as at March 31, 2021 were ₹216.42 crore due from six customers, each having more than 5% of total outstanding trade receivables. The trade receivables turnover ratio changed by more than 25% in FY2022-23 because credit revenue reduced while receivables increased due to a higher credit period with certain insurance companies/TPAs. - Operating cash flow exceeds PAT, but no dividends ever paid while costs are capitalised into projects
Minor- CFO exceeded PAT in each of FY2022 through FY2026, with CFO/PAT of 1.23x in FY2022 and 1.69x in FY2026. The Board did not recommend any dividend for FY2021-22, FY2022-23, FY2023-24, FY2025, or FY2026, citing long-term objectives or business purposes. Borrowing costs capitalised towards qualifying assets were ₹4.58 crore in FY2023 and ₹5.34 crore in FY2024 at 9.45% p.a., and ₹1.8 crore in FY2025 at 9.23% p.a., falling to Nil in FY2026.
What to watch
- Land exchange consummation. The proposed land exchange with SKMC, upon consummation, will cause the 43-year lease arrangements (November 2010 to March 2053) to cease to exist and will lead to removal of the corporate guarantee given by KMC to SKMC, as disclosed in the AGM notice dated 3rd Sep 2026.
- Shareholder vote on RPT resolution. The vote on Material Related Party Transactions takes place at the 43rd Annual General Meeting on Monday, 28 September 2026.
- Drawdown under expanded limit. Whether KMC draws down additional borrowings under the ₹700 crore limit following shareholder approval at the 43rd AGM on September 28, 2026.
- Guarantee invocation. Whether KMC's corporate guarantee to State Bank of India for SKMCIL's loan (₹98.57 crore as of February 11, 2026) is invoked or increased, given the reciprocal guarantee of ₹98.4 crore from SKMCIL.
- CARO recurrence. Whether the FY2025-26 pattern of PF/ESI/income-tax remittance delays and disputed statutory dues (net of ₹31.19 lakhs deposited under protest) recurs, resolves, or escalates in the FY2026-27 report.
Bottom line: This is a disclosed and audited record with genuine cash generation and a clean revenue profile. The risk sits in the related-party architecture: a holding company that both guarantees KMC's loans and draws on KMC's guarantees, a promoter family that dominates board, pay, and the counterparty's shareholding, and a borrowing limit being expanded 3.5 times while the promoter's own shares are encumbered. Read the related-party note with that in mind, and watch the September 28 AGM vote and the land swap consummation.